Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease.
Many degenerative disease processes associated with aging result from enhanced extracellular matrix (ECM) breakdown. Concomitant with aberrant matrix destruction are alterations in levels of reactive oxygen species (ROS) generating and detoxification systems. ROS function as second messengers due to their ability to react with wide range of biomolecules resulting in modification of an array of signaling networks. ROS can activate upstream kinases (MKK) responsible for MAPK activation and restrict the activity of their inhibitory phosphatases. Here we focus on the redox-sensitive signaling components that control the expression of MMP-1, which is largely responsible for maintaining ECM homeostasis. Numerous disease processes are associated with shifts in steady state ROS levels that influence overall ECM degradation. This review highlights the redox-sensitive regulatory signals that control the expression of the primary initiating protease MMP-1 and provides strong rational for the use of antioxidant based therapies for treatment of degenerative disorders associated with aberrant matrix destruction.
Kar
Supriya
S
Centers for Immunology & Microbial Disease, Albany Medical College, Albany, NY 12208, United States.
Subbaram
Sita
S
Carrico
Pauline M
PM
Melendez
J Andrés
JA
D000818:Animals; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D020935:MAP Kinase Signaling System; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism*; D019636:Neurodegenerative Diseases / Q000201:enzymology* / Q000503:physiopathology*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D017382:Reactive Oxygen Species / Q000378:metabolism
D005609:Free Radicals; D017382:Reactive Oxygen Species; D020781:Matrix Metalloproteinase 1
Bioessays. 1998 Aug;20(8):615-26
9780836
Am J Pathol. 2009 Jan;174(1):101-14
19116368
J Biol Chem. 2004 Apr 23;279(17):17690-6
14764579
J Cell Physiol. 2007 Apr;211(1):19-26
17167774
Antioxid Redox Signal. 2008 May;10(5):843-89
18220476
Biochem Biophys Res Commun. 1993 Oct 15;196(1):7-11
8216337
J Mol Med (Berl). 1996 Oct;74(10):589-607
8912180
Atherosclerosis. 2003 Mar;167(1):45-53
12618267
Int J Biochem Cell Biol. 2008;40(6-7):1362-78
18258475
J Biol Chem. 2004 Feb 13;279(7):5397-404
14645243
J Biol Chem. 1998 May 1;273(18):11044-8
9556587
Cell. 1992 Dec 11;71(6):955-61
1458541
Eur J Dermatol. 2006 Jul-Aug;16(4):375-9
16935793
J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27
12235282
Mol Cell Biol. 2003 Mar;23(5):1808-16
12588998
J Cosmet Sci. 2006 Jul-Aug;57(4):279-89
16957808
Crit Rev Eukaryot Gene Expr. 1996;6(4):391-411
8959374
J Biol Chem. 2002 Jun 7;277(23):20336-42
11916965
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):786-91
11254539
Biochem J. 1998 Aug 1;333 ( Pt 3):581-9
9677316
Biochemistry. 2006 Jul 18;45(28):8476-87
16834321
Matrix Suppl. 1992;1:200
1480023
J Biol Chem. 1998 Dec 4;273(49):32554-60
9829991
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3844-8
8170999
J Biol Chem. 2004 Jul 9;279(28):29857-62
15123696
Mutat Res. 1995 Oct;338(1-6):115-28
7565867
Curr Opin Struct Biol. 2004 Dec;14(6):679-86
15582391
Am J Physiol Lung Cell Mol Physiol. 2001 Dec;281(6):L1444-52
11704541
J Biol Chem. 2006 May 19;281(20):14100-10
16569638
J Invest Dermatol. 1991 Oct;97(4):679-85
1940438
J Immunol. 1998 Oct 1;161(7):3340-6
9759850
Neurosci Lett. 2000 Sep 22;291(3):201-3
10984641
Proc Natl Acad Sci U S A. 1990 Jan;87(1):364-8
2153297
Free Radic Biol Med. 2000 Jul 1;29(1):8-16
10962200
Biochem Biophys Res Commun. 2004 Feb 27;315(1):240-5
15013452
Nat Rev Mol Cell Biol. 2007 Feb;8(2):113-26
17245413
Proc Am Thorac Soc. 2006 Aug;3(6):477
16921115
Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L46-57
16473865
FEBS J. 2008 Jan;275(1):69-88
18067579
Pharmacol Rev. 2002 Dec;54(4):619-34
12429871
Int J Biochem Cell Biol. 2005 Feb;37(2):283-8
15474975
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13136-41
10557286
J Nutr. 2005 Dec;135(12):2767-73
16317118
Biochim Biophys Acta. 2002 Apr 24;1586(3):265-74
11997078
J Immunol. 1998 Jun 1;160(11):5374-81
9605137
J Mol Med (Berl). 2009 Mar;87(3):261-72
19034402
Oncogene. 1997 Jun 5;14(22):2651-60
9178763
Pathol Biol (Paris). 2003 Dec;51(10):569-73
14622947
J Clin Invest. 2000 Oct;106(7):857-66
11018073
Mol Cell Biol. 2004 Jun;24(12):5496-509
15169910
Nature. 1994 Aug 18;370(6490):555-7
8052310
J Biol Chem. 2003 Jan 24;278(4):2309-16
12431981
Circulation. 1995 Sep 15;92(6):1393-8
7664418
J Cell Physiol. 2010 Oct;225(1):52-62
20648623
Photochem Photobiol. 1999 Feb;69(2):154-7
10048311
FEBS Lett. 1997 Dec 1;418(3):291-6
9428730
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5634-9
12719531
J Cell Biochem. 1996 Apr;61(1):139-51
8726363
J Invest Dermatol. 2000 Aug;115(2):213-8
10951238
J Biol Chem. 2001 Apr 27;276(17):14264-70
11297530
Int J Mol Med. 2005 Oct;16(4):677-81
16142404
Nature. 2002 Dec 19-26;420(6917):868-74
12490960
J Biol Chem. 1999 Sep 3;274(36):25869-76
10464329
Cell. 2005 Mar 11;120(5):649-61
15766528
J Biol Chem. 2004 Jun 25;279(26):27257-62
15084586
Clin Cancer Res. 2003 Jan;9(1):424-32
12538496
J Biol Chem. 2002 Aug 30;277(35):32360-8
12060661
FEBS Lett. 1996 Apr 29;385(1-2):63-6
8641468
J Invest Dermatol. 1997 Mar;108(3):281-4
9036925
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3633-6
1673789
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11584-9
9751709
FASEB J. 2004 Dec;18(15):1897-9
15456740
Cancer Res. 2006 May 1;66(9):4888-94
16651445
FASEB J. 1999 May;13(8):781-92
10224222
Mol Cell Biol. 1987 Jun;7(6):2256-66
3037355
Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10
16622845
Am J Physiol Lung Cell Mol Physiol. 2002 Dec;283(6):L1161-78
12424143
J Investig Dermatol Symp Proc. 1998 Aug;3(1):61-8
9732061
Front Biosci. 2006 Jan 01;11:529-43
16146751
J Biol Chem. 2002 Oct 11;277(41):38079-86
12154090
Biochem Biophys Res Commun. 2008 Feb 1;366(1):23-8
18036554
Cancer Res. 1998 Dec 1;58(23):5321-5
9850057